KemPharm, Inc. (US OTC:KMPH)

About the company

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

22

CEO

Travis C. Mickle

Exchange

US OTC

Website

http://www.kempharm.com

$15.00M

Total Revenue

22

Employees

$6.02M

Market Capitalization

-0.35

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$11M

Operating Margin (in %)

Total operating margin

$-12M

Net Margin (in %)

Total net margin

$-18M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12030.90 1376.00 5.13 18.97 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7525.41 4837.00 1.29 51.34 3.02
Bausch Health Cos., Inc. BHC 6195.15 8597.00 8.65 -3.27 -21.96
Jazz Pharmaceuticals Plc JAZZ 6129.78 2188.00 2.12 22.40 12.81
United Therapeutics Corp. UTHR 5064.54 1443.00 1.76 9.77 36.59
MyoKardia, Inc. MYOK 4325.84 34.00 12.57 -13.95 -201.73
Axsome Therapeutics, Inc. AXSM 3004.40 None 20.39 -33.40 None
Pacira Biosciences, Inc. PCRX 2374.68 435.00 6.37 -5654.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2181.92 9.00 2.56 -3.37 -413.06
Corcept Therapeutics, Inc. CORT 2054.48 335.00 4.72 19.36 31.64
Prestige Consumer Healthcare, Inc. PBH 1862.52 963.00 1.57 13.14 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1617.30 0.00 4.32 -15.83 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1595.90 440.00 -22.59 18.82 19.14
Revolution Medicines, Inc. RVMD 1567.34 48.00 4.07 -22.14 -146.29
Innoviva, Inc. INVA 1539.06 285.00 3.64 7.96 66.41
Intercept Pharmaceuticals, Inc. ICPT 1409.60 272.00 -41.95 -4.11 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Zogenix, Inc. ZGNX 1272.60 5.00 3.47 -2.99 -241.62
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1136.58 88.00 -7.98 -4.61 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1053.50 327.00 2.63 20.67 15.90
Endo International Plc ENDP 777.48 3014.00 -1.06 -2.77 -9.09
BellRing Brands, Inc. BRBR 771.22 954.00 -0.42 5.85 13.98
Assembly Biosciences, Inc. ASMB 693.39 16.00 3.11 -6.97 -601.75
Eagle Pharmaceuticals, Inc. EGRX 648.90 192.00 3.49 257.50 1.29
Aerie Pharmaceuticals, Inc. AERI 616.86 79.00 4.89 -3.05 -252.92
Collegium Pharmaceutical, Inc. COLL 581.06 299.00 4.16 -44.97 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 543.56 119.00 5.29 12.39 36.09
Anika Therapeutics, Inc. ANIK 494.20 125.00 1.71 17.83 22.73
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 392.84 130.00 5.62 -53.37 -5.01
ANI Pharmaceuticals, Inc. ANIP 367.56 203.00 1.88 -235.62 -0.67
Albireo Pharma, Inc. ALBO 331.24 11.00 3.37 -4.33 -730.55
MEI Pharma, Inc. MEIP 284.69 5.00 4.90 -7.30 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 161.66 None 2.63 -7.83 None
Marinus Pharmaceuticals, Inc. MRNS 161.60 0.00 6.26 -2.40 None
Cerecor, Inc. CERC 119.60 7.00 7.65 -5.31 -429.22
Ampio Pharmaceuticals, Inc. AMPE 95.81 1.00 67.00 -5.15 None
Evoke Pharma, Inc. EVOK 86.88 None 30.17 -12.93 None
AcelRx Pharmaceuticals, Inc. ACRX 85.60 2.00 -1.57 -1.53 -644.25
CTI BioPharma Corp. CTIC 83.78 3.00 3.74 -2.03 -111.83
Zynerba Pharmaceuticals, Inc. ZYNE 78.66 0.00 1.29 -2.19 -699.94
Adamas Pharmaceuticals, Inc. ADMS 71.96 57.00 -4.59 -0.78 -160.44
Aclaris Therapeutics, Inc. ACRS 68.88 4.00 1.21 -0.50 None
Oramed Pharmaceuticals, Inc. ORMP 60.48 3.00 4.87 -4.73 -464.15
Cassava Sciences, Inc. SAVA 59.28 41.00 3.12 -13.00 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.20 47.00 1.00 -10.93 -9.59
SCYNEXIS, Inc. SCYX 48.95 0.00 10.28 -1.26 -30.84
Natural Alternatives International, Inc. NAII 46.55 114.00 0.64 -12.31 -3.19
IsoRay, Inc. ISR 42.88 9.00 8.00 -12.80 -36.08
Lipocine, Inc. LPCN 39.60 0.00 9.43 -2.64 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.00 0.00 -2.59 -2.86 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.80 3.00 2.59 -1.76 -264.21
Regulus Therapeutics, Inc. RGLS 17.64 0.00 1.56 -0.82 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.65 8.00 0.67 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.66 None 1.37 -0.25 None
VIVUS, Inc. VVUS 8.88 73.00 -0.20 -0.30 -39.28
Hepion Pharmaceuticals, Inc. HEPA 7.38 None 2.31 -0.62 None
Sonoma Pharmaceuticals, Inc. SNOA 6.37 19.00 1.01 -2.04 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Tonix Pharmaceuticals Holding Corp. TNXP 4.27 None 1.07 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

KemPharm Inc.

6d ago, source: MarketWatch

Chief Business Officer 10,000 Acquisition at $0.39 per share. 3,900 ...

KemPharm Issues Letter to Shareholders

21d ago, source: YAHOO!

CELEBRATION, Fla., June 18, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced ...

Financials KemPharm

29d ago, source: Business Insider

© 2020 Insider Inc. and finanzen.net GmbH All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy ...

Top Companies To Short As Stock Market Optimism Dips

26d ago, source: Forbes

Price of Inspired Entertainment Inc compared to its Simple Moving Average Our final Top Short today is KemPharm Inc, a clinical-stage specialty pharmaceutical company engaged in the discovery and ...

Acura Pharmaceuticals Announces First Quarter 2020 Financial Results

9d ago, source: Stockhouse

June 29, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical ... AVERSION® Technology is also licensed to KemPharm for use in certain of their ...

KemPharm Issues Letter to Shareholders

21d ago, source: Business Insider

June 18, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced that Travis C.

KemPharm Inc.

15d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.